A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

Strope, 2010, Prostate cancer screening: current status and future perspectives, Nat Rev Urol, 7, 487, 10.1038/nrurol.2010.120 Thompson, 2007, Guideline for the management of clinically localized prostate cancer: 2007 update, J Urol, 177, 2106, 10.1016/j.juro.2007.03.003 Cooperberg, 2010, Time trends and local variation in primary treatment of localized prostate cancer, J Clin Oncol, 28, 1117, 10.1200/JCO.2009.26.0133 Sanda, 2008, Quality of life and satisfaction with outcome among prostate-cancer survivors, N Engl J Med, 358, 1250, 10.1056/NEJMoa074311 Moyer, 2012, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 120, 10.7326/0003-4819-157-2-201207170-00459 Qaseem, 2013, Screening for prostate cancer: a guidance statement from the clinical guidelines committee of the American College of Physicians, Ann Intern Med, 158, 761, 10.7326/0003-4819-158-10-201305210-00633 Cooperberg, 2011, Active surveillance for prostate cancer: progress and promise, J Clin Oncol, 29, 3669, 10.1200/JCO.2011.34.9738 Cooperberg, 2005, The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy, J Urol, 173, 1938, 10.1097/01.ju.0000158155.33890.e7 Stephenson, 2009, Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era, J Clin Oncol, 27, 4300, 10.1200/JCO.2008.18.2501 Dong, 2008, Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice, J Urol, 180, 150, 10.1016/j.juro.2008.03.053 Ploussard, 2011, The contemporary concept of significant versus insignificant prostate cancer, Eur Urol, 60, 291, 10.1016/j.eururo.2011.05.006 King, 2000, Prostate biopsy grading errors: a sampling problem?, Int J Cancer, 90, 326, 10.1002/1097-0215(20001220)90:6<326::AID-IJC3>3.0.CO;2-J Conti, 2009, Pathological outcomes of candidates for active surveillance of prostate cancer, J Urol, 181, 1628, 10.1016/j.juro.2008.11.107 Müntener, 2008, Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy, Eur Urol, 53, 767, 10.1016/j.eururo.2007.11.016 Tomlins, 2007, Integrative molecular concept modeling of prostate cancer progression, Nat Genet, 39, 41, 10.1038/ng1935 Makarov, 2009, Biomarkers for prostate cancer, Annu Rev Med, 60, 139, 10.1146/annurev.med.60.042307.110714 Singh, 2002, Gene expression correlates of clinical prostate cancer behavior, Cancer Cell, 1, 203, 10.1016/S1535-6108(02)00030-2 Cheville, 2008, Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy, J Clin Oncol, 26, 3930, 10.1200/JCO.2007.15.6752 Ding, 2011, SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression, Nature, 470, 269, 10.1038/nature09677 Cuzick, 2012, Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort, Br J Cancer, 106, 1095, 10.1038/bjc.2012.39 Berger, 2011, The genomic complexity of primary human prostate cancer, Nature, 470, 214, 10.1038/nature09744 Squire, 2011, Prostate cancer as a model system for genetic diversity in tumors, Adv Cancer Res, 112, 183, 10.1016/B978-0-12-387688-1.00007-7 Gray, 2009, Weighted analyses for cohort sampling designs, Lifetime Data Anal, 15, 24, 10.1007/s10985-008-9095-z Chen, 1999, Case-cohort and case-control analysis with Cox's model, Biometrika, 86, 755, 10.1093/biomet/86.4.755 McShane, 2005, Reporting recommendations for tumor marker prognostic studies, J Clin Oncol, 23, 9067, 10.1200/JCO.2004.01.0454 Cooperberg, 2011, Outcomes of active surveillance for men with intermediate-risk prostate cancer, J Clin Oncol, 29, 228, 10.1200/JCO.2010.31.4252 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Magi-Galluzzi, 2007, RNA yields and RT-PCR gene expression profiles obtained from manual-microdissected, fixed-paraffin-embedded tissue (FPET) from prostate adenocarcinomas, Mod Pathol, 20, 352A Magi-Galluzzi, 2010, RNA yields and RT-PCR gene expression profiles obtained from manual-microdissected fixed paraffin-embedded prostate cancer needle core biopsies, Mod Pathol, 23, 205A Knezevic, 2013, Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies, BMC Genomics, 14, 690, 10.1186/1471-2164-14-690 Cox, 1972, Regression models and life tables, J R Stat Soc Series B Stat Methodol, 43, 187 Goldstein, 2008, Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features, J Clin Oncol, 26, 4063, 10.1200/JCO.2007.14.4501 Storey, 2001 Cooperberg, 2009, Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis, J Natl Cancer Inst, 101, 878, 10.1093/jnci/djp122 NCCN clinical practice guidelines in oncology (NCCN Guidelines). Prostate cancer, version 2.2013. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#prostate. Vickers, 2006, Decision curve analysis: a novel method for evaluating prediction models, Med Decis Making, 26, 565, 10.1177/0272989X06295361 Eggener, 2011, Predicting 15-year prostate cancer specific mortality after radical prostatectomy, J Urol, 185, 869, 10.1016/j.juro.2010.10.057 Hong, 2014, Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance, Eur Urol, 66, 214, 10.1016/j.eururo.2013.08.001 Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 Vickers, 2009, Net reclassification improvement and decision theory, Stat Med, 28, 525, 10.1002/sim.3087 Gu, 2009, Estimating the capacity for improvement in risk prediction with a marker, Biostatistics, 10, 172, 10.1093/biostatistics/kxn025 Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, 367, 203, 10.1056/NEJMoa1113162 Donin, 2013, Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy, Urology, 82, 148, 10.1016/j.urology.2013.03.054 Ganz, 2011, NIH State-of-the-Science Conference Statement: role of active surveillance in the management of men with localized prostate cancer, NIH Consens State Sci Statements, 28, 1 Reese, 2012, The quantitative Gleason score improves prostate cancer risk assessment, Cancer, 118, 6046, 10.1002/cncr.27670 Nam, 2010, Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy, J Urol, 183, 963, 10.1016/j.juro.2009.11.043 Fujita, 2009, Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance, J Urol, 182, 2664, 10.1016/j.juro.2009.08.044 Hayes, 2010, Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis, JAMA, 304, 2373, 10.1001/jama.2010.1720 Carter, 2012, Gleason score 6 adenocarcinoma: should it be labeled as cancer?, J Clin Oncol, 30, 4294, 10.1200/JCO.2012.44.0586 Esserman, 2013, Overdiagnosis and overtreatment in cancer: an opportunity for improvement, JAMA, 310, 797, 10.1001/jama.2013.108415 Penney, 2011, mRNA expression signature of Gleason grade predicts lethal prostate cancer, J Clin Oncol, 29, 2391, 10.1200/JCO.2010.32.6421 Crager, 2010, Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean, Stat Med, 29, 33, 10.1002/sim.3789